The Translational Award
Open
Deadline: -
Funding body:
The Brain Tumor Charity
This call funds projects aimed at accelerating the translation of discoveries obtained through basic research towards the development of new therapeutic options for brain tumours.
The grants support proof-of-concept studies, both ex vivo and in vivo, with an estimated duration of between 12 and 18 months.
Projects must demonstrate clear potential to contribute to improving the diagnosis, treatment or quality of life of people affected by primary brain tumours.
Funding: Up to £400,000 per project.
Application deadlines:
The deadline for submitting the pre-proposal is 25 November 2026 and, for submitting the full proposal by invitation, 12 May 2027.
This call does not fund indirect costs (overhead), so express authorisation must be requested from the Foundation before applying, by submitting a commitment to co-finance the overhead by 11 November 2026 email link(ELIMINAR).
Furthermore, if the recruitment of staff funded by the grant is requested, an additional co-financing commitment must be provided to guarantee coverage of any employment costs not covered by the grant awarded.
Requirements
The call is open to researchers from any country, with the aim of supporting excellent projects that drive the development of new therapeutic options for brain tumours.
Proposals must be submitted through academic institutions, while applications from biotechnology companies will be assessed on an individual basis.
Each researcher may lead a single proposal per call, and participating teams must demonstrate the necessary experience to translate research results into real benefits for patients and clinical practice.